Carl Zeiss Meditec AG Stock Swiss Exchange

Equities

AFX

DE0005313704

Advanced Medical Equipment & Technology

Delayed Swiss Exchange 12:35:24 2024-04-02 am EDT 5-day change 1st Jan Change
174.6 CHF +38.90% Intraday chart for Carl Zeiss Meditec AG -.--% +0.03%

Financials

Sales 2024 * 2.24B 2.42B 2.22B Sales 2025 * 2.52B 2.73B 2.49B Capitalization 8.49B 9.2B 8.41B
Net income 2024 * 255M 276M 253M Net income 2025 * 316M 342M 313M EV / Sales 2024 * 3.97 x
Net Debt 2024 * 396M 429M 392M Net Debt 2025 * 477M 517M 473M EV / Sales 2025 * 3.56 x
P/E ratio 2024 *
33.3 x
P/E ratio 2025 *
26.9 x
Employees 4,950
Yield 2024 *
1.11%
Yield 2025 *
1.27%
Free-Float 40.86%
More Fundamentals * Assessed data
Dynamic Chart
1 day+38.90%
3 months+0.03%
6 months+0.03%
Current year+0.03%
More quotes
1 week
174.60
Extreme 174.6
174.60
1 month
174.60
Extreme 174.6
174.60
Current year
174.55
Extreme 174.55
174.60
1 year
174.55
Extreme 174.55
174.60
3 years
127.10
Extreme 127.1
174.60
5 years
94.40
Extreme 94.4
174.60
10 years
22.53
Extreme 22.53
174.60
More quotes
Managers TitleAgeSince
Chief Executive Officer 51 21-12-30
Director of Finance/CFO 59 18-09-30
Director/Board Member 57 09-12-14
Members of the board TitleAgeSince
Director/Board Member 57 09-12-14
Chairman 60 20-06-24
Director/Board Member 55 21-05-26
More insiders
Date Price Change
24-05-22 174.6 -.--%
24-05-21 174.6 -.--%
24-05-17 174.6 -.--%
24-05-16 174.6 -.--%
24-05-15 174.6 -.--%

Delayed Quote Swiss Exchange, April 02, 2024 at 12:35 am EDT

More quotes
Carl Zeiss Meditec AG is a Germany-based medical technology and device company. It offers offers complete solutions to diagnose and treat ophtalmic diseases, visualization solutions for microsurgery and other technologies, such as intraoperative radiotherapy. The Company operates in two segments: Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment comprises activities in the area of ophthalmology, such as intraocular lenses, surgical visualization solutions and medical laser and diagnostic systems. The Microsurgery segment includes activities of neuro, ear, nose and throat surgery, as well as the activities in the field of intraoperative radiation. The Company has various production sites in Europe, the United States and Asia.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
15
Last Close Price
94.9 EUR
Average target price
105.5 EUR
Spread / Average Target
+11.20%
Consensus